Aligos Therapeutics Inc (ALGS) support and resistance · rev $3.6M
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
This page maps Aligos Therapeutics Inc (ALGS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
ALGS currently screens at market cap $44.1M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ALGS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ALGS quote page for the session range and the stock page for the full model.
Not investment advice.